Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06657248 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant

Study acronym: UNI_XF_PRO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Mar 2026 to Apr 2, 2026 · Site details revised at 4 of 4 sitesv6 Show 2 more changesShow less
    • Start date changed from estimate of Mar 2026 to Apr 2, 2026
    • Site details revised at 4 of 4 sites
  2. Primary completion date: Feb 2026 to Oct 2027 Completion date: Feb 2031 to Oct 2032 · Start date: Jan 2026 to Mar 2026v5 Show 2 more changesShow less
    • Completion date: Feb 2031 to Oct 2032
    • Start date: Jan 2026 to Mar 2026
  3. Start date: Dec 2025 to Jan 2026v4
  4. Start date: Nov 2025 to Dec 2025 Study description expanded, about 60 wordsv3 Show 1 more changeShow less
    • Study description expanded, about 60 words

    See this version in full on ClinicalTrials.gov ↗

  5. Start date: Nov 2024 to Nov 2025v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aesculap AG
32 trials monitored
See 6 trials at risk
The study is designed as a prospective, observational, mid-term, multi-center follow-up study. It is planned to include 150 patients from 4 different study centres in Germany.
Trial Details
NCT Number NCT06657248
Lead Sponsor Aesculap AG
Collaborators: Raylytic GmbH
Conditions Gonarthritis, Degenerative Disease
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov